Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims:Several studies suggested that serum cystatin C (CysC) is more useful than serum creatinine (Cr) for the assessment of renal function in patients with liver cirrhosis. This study evaluated the clinical significance of CysC in patients with cirrhotic ascites and normal Cr level. Methods: We enrolled patients with cirrhotic ascites and a normal serum Cr level (<1.2 mg/dL). GFR was measured by ^(99m)Tc- DTPA renal scan. Serum Cr, CysC, and Cr clearance (CCr) were measured on the same day. Significant renal impairment and severe renal impairment were defined as GFR <60 mL/min and GFR <30 mL/min, respectively. Results: Eighty-nine patients with cirrhotic ascites were enrolled in the study (63 men and 26 women; age, 55±11 years). Forty-seven (52.8%) and 42 (47.2%) patients were in Child-Pugh grade B and C, respectively. Serum Cr and CysC levels and GFR were 0.8±0.2 mg/dL, 1.1±0.3 mg/L, and 73.4±25.5 mL/min, respectively. Significant and severe renal impairment were noted in 28 (31.5%) and 2 (2.2%) patients, respectively. GFR was well correlated with serum Cr, CysC, and e-GFRMDRD, while it was not correlated with e-GFRC&G. In multivariate analysis, only CysC was significantly correlated with GFR (β, 45.620; 95% CI, 23.042-68.198; P<0.001). Serum CysC level was the only independent predictor for significant renal impairment. Conclusions: Significant renal dysfunction was not rare in patients with cirrhotic ascites, even their serum Cr level is normal. Serum CysC is a useful marker for detecting significant renal dysfunction in these patients.
Abstract
Background/Aims:Several studies suggested that serum cystatin C (CysC) is more useful than serum creatinine (Cr) for the assessment of renal function in patients with liver cirrhosis. This study evaluated the clinical significance of CysC in patients with cirrhotic ascites and normal Cr level. Methods: We enrolled patients with cirrhotic ascites and a normal serum Cr level (<1.2 mg/dL). GFR was measured by ^(99m)Tc- DTPA renal scan. Serum Cr, CysC, and Cr clearance (CCr) were measured on the same day. Significant renal impairment and severe renal impairment were defined as GFR <60 mL/min and GFR <30 mL/min, respectively. Results: Eighty-nine patients with cirrhotic ascites were enrolled in the study (63 men and 26 women; age, 55±11 years). Forty-seven (52.8%) and 42 (47.2%) patients were in Child-Pugh grade B and C, respectively. Serum Cr and CysC levels and GFR were 0.8±0.2 mg/dL, 1.1±0.3 mg/L, and 73.4±25.5 mL/min, respectively. Significant and severe renal impairment were noted in 28 (31.5%) and 2 (2.2%) patients, respectively. GFR was well correlated with serum Cr, CysC, and e-GFRMDRD, while it was not correlated with e-GFRC&G. In multivariate analysis, only CysC was significantly correlated with GFR (β, 45.620; 95% CI, 23.042-68.198; P<0.001). Serum CysC level was the only independent predictor for significant renal impairment. Conclusions: Significant renal dysfunction was not rare in patients with cirrhotic ascites, even their serum Cr level is normal. Serum CysC is a useful marker for detecting significant renal dysfunction in these patients.
참고문헌 (50)
- Garcia-Tsao G, "Acute kidney injury in cirrhosis", Hepatology, 48, pp.2064~2077 (2008)
- Arroyo V, "Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management", J Hepatol, 38(1), pp.69~89 (2003)
- Cholongitas E, "Review article: renal function assessment in cirrhosis - difficulties and alternative measurements", Aliment Pharmacol Ther, 26, pp.969~978 (2007)
- Pirlich M, "Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites", Hepatology, 32, pp.1208~1215 (2000)
- Figueiredo FA, "Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease", Liver Transpl, 6, pp.575~581 (2000)
- Cockcroft DW, "Prediction of creatinine clearance from serum creatinine", Nephron, 16, pp.31~41 (1976)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group", Ann Intern Med, 130, pp.461~470 (1999)
- Papadakis MA, "Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study", Am J Med, 82, pp.945~952 (1987)
- Stevens LA, "Assessing kidney function-measured and estimated glomerular filtration rate", N Engl J Med, 354, pp.2473~2483 (2006)
- Herget-Rosenthal S, "Cystatin C: efficacy as screening test for reduced glomerular filtration rate", Am J Nephrol, 20, pp.97~102 (2000)
- Gerbes AL, "Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver", Gut, 50, pp.106~110 (2002)
- Dharnidharka VR, "Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis", Am J Kidney Dis, 40, pp.221~226 (2002)
- Demirtaş S, "Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome", Clin Chim Acta, 311, pp.81~89 (2001)
- Orlando R, "Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis", Clin Chem, 48, pp.850~858 (2002)
- 정미연, "Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis", Clinical and Molecular Hepatology, 16(3), pp.301~307 (2010), 대한간학회
- Larsen K, "Creatinine assay by a reaction-kinetic principle", Clin Chim Acta, 41, pp.209~217 (1972)
- Pugh RN, "Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
- Wiesner R, "Model for end-stage liver disease (MELD) and allocation of donor livers", Gastroenterology, 124, pp.91~96 (2003)
- Gordon I, "Can technetium-99m- mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect", J Nucl Med, 33, pp.2090~2093 (1992)
- National Kidney Foundation, "K", DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, 2002, pp.39(2), 1~266
- Arroyo V, "Pathogenesis and treatment of hepatorenal syndrome", Semin Liver Dis, 28, pp.81~95 (2008)
- Seo YS, "Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels", Liver Int, 29, pp.1521~1527 (2009)
- Ginès A, "Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites", Gastroenterology, 105, pp.229~236 (1993)
- Fernández-Esparrach G, "A prognostic model for predicting survival in cirrhosis with ascites", J Hepatol, 34, pp.46~52 (2001)
- Longheval G, "Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis", Liver Transpl, 9, pp.260~267 (2003)
- Sherman DS, "Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls", Am J Kidney Dis, 41, pp.269~278 (2003)
- Arroyo V, "Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome", J Hepatol, 46, pp.935~946 (2007)
- Francoz C, "The evaluation of renal function and disease in patients with cirrhosis", J Hepatol, 52, pp.605~613 (2010)
- Peake M, "Measurement of serum creatinine-current status and future goals", Clin Biochem Rev, 27, pp.173~184 (2006)
- Spencer K, "Analytical reviews in clinical biochemistry: the estimation of creatinine", Ann Clin Biochem, 23, pp.1~25 (1986)
- Badiou S, "Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer", J Clin Lab Anal, 17, pp.235~240 (2003)
- Takabatake T, "Low serum creatinine levels in severe hepatic disease", Arch Intern Med, 148, pp.1313~1315 (1988)
- Mullane JF, "Development of renal impairment in Laennec's cirrhosis", Ann Surg, 174, pp.892~901 (1971)
- Caregaro L, "Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis", Arch Intern Med, 154, pp.201~205 (1994)
- DeSanto NG, "Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting", Nephron, 70, pp.421~424 (1995)
- Roy L, "Glomerular filtration rate measurement in cirrhotic patients with renal failure", Clin Nephrol, 50, pp.342~346 (1998)
- Proulx NL, "Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis", Nephrol Dial Transplant, 20, pp.1617~1622 (2005)
- Orlando R, "Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis", Clin Nephrol, 51, pp.341~347 (1999)
- Hoek FJ, "A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate", Nephrol Dial Transplant, 18, pp.2024~2031 (2003)
- Gonwa TA, "Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations", Liver Transpl, 10, pp.301~309 (2004)
- Sundaraiya S, "Tc-99m DTPA renography in children following renal transplantation: its value in the evaluation of rejection", Pediatr Transplant, 11, pp.771~776 (2007)
- Herget-Rosenthal S, "How to estimate GFR-serum creatinine, serum cystatin C or equations", Clin Biochem, 40, pp.153~161 (2007)
- Rahn KH, "How to assess glomerular function and damage in humans", J Hypertens, 17, pp.309~317 (1999)
- De Santo NG, "Measurement of glomerular filtration rate by the 99mTc-DTPA renogram is less precise than measured and predicted creatinine clearance", Nephron, 81, pp.136~140 (1999)
- Woitas RP, "Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis", Clin Chem, 46, pp.712~715 (2000)
- Randers E, "Plasma cystatin C as a marker of renal function in patients with liver cirrhosis", Scand J Clin Lab Invest, 62, pp.129~134 (2002)
- Berenguer-Pina JJ, "Cystatin C: a marker of glomerular filtration rate in liver transplantation", Transplant Proc, 34, pp.268~269 (2002)
- Laterza OF, "Cystatin C: an improved estimator of glomerular filtration rate", Clin Chem, 48, pp.699~707 (2002)
- Foster J, "Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate", Pediatr Nephrol, 21, pp.235~238 (2006)
- Podracka L, "Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients", Pediatr Transplant, 9, pp.28~32 (2005)